Unlike "one-size-fits-all" approaches, personalized medicine is not easy to test. The first step is to identify a subgroup at risk and the second is to show the improvement of a patient-centered outcome with the intervention in the subgroup. https://t.co/W
RT @BioMedCentral: A Review published in @Crit_Care highlights emerging opportunities and continued challenges for personalizing therapy fo…
RT @Infermiere_line: Promises and challenges of #PersonalizedMedicine to guide ARDS therapy @Crit_Care | #ARDS https://t.co/o2i0oUIaEk
Promises and challenges of #PersonalizedMedicine to guide ARDS therapy @Crit_Care | #ARDS https://t.co/o2i0oUIaEk